Analytical testing, QC

People on the Move

Outsourcing-Pharma’s Hiring and Firing Roundup October ‘17

31-Oct-2017 By Melissa Fassbender

This month’s round up includes Adent’s new product management director who joins the company from Eli Lily and a new CEO at Clinipace, as the CRO’s co-founder steps down after 14 years.

Concept acquires preclinical CRO following search to add translational biology capabilities

30-Oct-2017 By Melissa Fassbender

Concept Life Sciences has acquired Aquila BioMedical, citing the CRO’s specific skill set, which will allow the company to provide services in areas “not previously accessible,” says executive chairman.

Single-source outsourcing model saves pharma sponsors $45m, Tufts report

26-Oct-2017 By Melissa Fassbender

Sponsors using a single-source outsourcing partner could potentially save up to $45m through reduced time to market, according to a recent Tufts study.

Cost, risk, on-time and in-full: Defining value in the customer-supplier relationship

19-Oct-2017 By Melissa Fassbender

Pharmaceutical companies are more likely than their suppliers to cite cost improvement over time as the most effective metric for measuring supplier performance, according to a recent report.

Powered by Scientist.com, VWR offers access to 2,200 CROs

17-Oct-2017 By Melissa Fassbender

The VWR Science Portal provides customers with access to the Scientist.com supplier network, including more than 2,200 contract research organizations (CROs).

AMRI: stand-alone analytical testing services launched ahead of regulatory changes

17-Oct-2017 By Melissa Fassbender

AMRI is offering its impurity solutions as a stand-alone service in response to new regulatory requirements that set limits for the amounts of elemental impurities in drug products.

BioMoti and CRO partner Pharmidex receive grant to advance cancer candidate

16-Oct-2017 By Melissa Fassbender

BioMoti and Pharmidex have received funding to advance proof-of-concept precision medicine studies – which if successful, could help secure pharma partnerships or additional investment, says BioMoti CEO.

Cambrex adds new development and analytical equipment in Italy

12-Oct-2017 By Melissa Fassbender

Cambrex Corporation has announced a new investment in its research and development (R&D) and manufacturing capabilities at its site in Paullo, Milan, Italy.

Printed meds accelerate clinical testing sans toxic solvents

05-Oct-2017 By Melissa Fassbender

A new technique for printing medications without using solvents can accelerate drug screening and clinical testing, say researchers.

With $150m in its pocket, new cancer startup will turn to CROs to ‘execute faster’

05-Oct-2017 By Melissa Fassbender

Cullinan Oncology has launched with $150m in funding, a focus on risk, and a business model through which it will rely on a global network of third-party vendors, says CEO.

Outsourcing-Pharma's Hiring and Firing Roundup September '17

02-Oct-2017 By Melissa Fassbender

This month’s roundup includes several executive level positions and two new hires at Envigo and Bracket.

Helomics, Indivumed partner on precision medicine platform

25-Sep-2017 By Melissa Fassbender

Pharma and diagnostic partners will gain access to a human cancer biospecimens and clinical data from patients to power clinical and translational research, says CRO.

New lab space to support CRO’s acceleration into 2018

18-Sep-2017 By Melissa Fassbender

Concept Life Sciences has added new laboratory space at its Alderley Park-based facility in Cheshire, UK to support discovery services growth.

Recipharm partners with CTC to reduce complexity of first-in-human studies

18-Sep-2017 By Melissa Fassbender

Recipharm is collaborating with the Swedish contract research organization (CRO) to provide a “start to finish service,” says the CDMO.

‘Refreshed with capital’ AMRI eyes acquisitions, looks to double revenue

06-Sep-2017 By Melissa Fassbender

AMRI has been acquired by a private equity firm and has already begun its search for “the next couple of acquisitions,” says its CEO – and the shopping list is long.

Pharma Finance

Mid-size CRO market update: battle for customers is heating up

06-Sep-2017 By Jason Monteleone, guest contributor

The mid-size contract research organization (CRO) sector continues to evolve and surprise experts with rich valuations – and what seems to be a never ending list of transactions.

LabCentral signs Science Exchange: outsourced services ‘increasingly important’

05-Sep-2017 By Melissa Fassbender

Cambridge-based LabCentral has signed on Science Exchange to provide its resident startups with access to outsourced services.

Cambrex adding $3.2m analytical lab at NC facility

30-Aug-2017 By Melissa Fassbender

Cambrex Corporation is adding a new $3.2m, 11,000 square foot analytical laboratory to its High Point, NC-based facility.

Dutch CRO Viroclinics acquired by PE firm

29-Aug-2017 By Melissa Fassbender

Viroclinics Biosciences is expanding its service offering – and eyeing acquisition – following an investment by Parcom Capital.

Eurofins Pharma Bioanalytical Services announces new consulting services

28-Aug-2017 By Melissa Fassbender

Eurofins Pharma Bioanalytical Services has launched a consulting program to support clients conducting large molecule preclinical and clinical studies.

ScinoPharm showcases water treatment tech at Baxdela API plant

17-Aug-2017 By Gareth Macdonald

ScinoPharm has emphasised its compliance with waste water treatment rules, weeks after being contracted to supply API for Melinta Therapeutics’ antibiotic Baxdela.

Boehringer Ingelheim taps Philogen DNA-encoded chemistry tech

31-Jul-2017 By Melissa Fassbender

Boehringer Ingelheim and Philogen have signed a multi-target research agreement to discover and optimize new small molecule therapeutics for unmet medical needs.

Outsourcing platform receives EU-US data security certification

25-Jul-2017 By Melissa Fassbender

Science Exchange has been certified under the EU-US Privacy Shield Framework after completing a seven-step process to demonstrate compliance with various data protection requirements.

Takeda, Schrödinger sign multi-target research collaboration

24-Jul-2017 By Melissa Fassbender

Takeda Pharmaceutical Company Limited and Schrödinger Inc. have formed a multi-target research collaboration that leverages Schrödinger’s in silico platform-driven drug discovery capabilities.

Eurofins acquires India-based preclinical CRO

24-Jul-2017 By Melissa Fassbender

Eurofins Scientific has acquired the India-based preclinical CRO Advinus Therapeutics after raising €650m.

Eli Lilly licenses Adimab antibody discovery and optimization tech

19-Jul-2017 By Melissa Fassbender

Adimab, LLC is transferring its proprietary antibody discovery and optimization platform to Lilly research sites in San Diego and New York.

SQI Diagnostics signs commercial contract with global biotech

19-Jul-2017 By Melissa Fassbender

SQI Diagnostics Inc. has signed an agreement to commercialize a custom multiplexed assay for a Waltham, MA-based global biotechnology company's blood disorder drug program.

ABL advancing HIV vaccine as part of 7 year, $318m contract

19-Jul-2017 By Melissa Fassbender

ABL, Inc. has been awarded a preclinical development support contract to help advance an HIV vaccine and other biologics candidates.

Alcami relocating headquarters to RTP, new jobs expected

17-Jul-2017 By Melissa Fassbender

Alcami is moving its global headquarters to Research Triangle Park (RTP) in Durham, North Carolina.

Spheryx awarded Ph II grant to modify tech for biologics industry

07-Jul-2017 By Melissa Fassbender

Spheryx, Inc. has been awarded a $1.5m grant over two years to support modifications to the company’s propriety protein aggregation detection and monitoring technology.

Pharma finance

It's a seller's market as buyers narrow therapeutic focus, says inVentiv

07-Jul-2017 By Melissa Fassbender

Biopharmaceutical dealmakers are narrowing in on therapeutic areas as company’s look to lead specific markets or gain a technical advantage.

Evotec: patient biobank access to advance drug discovery

26-Jun-2017 By Melissa Fassbender

Evotec has joined a consortium through which it gains access to a sample biobank in order to perform drug discovery based on unique kidney disease patient cohorts.

Researchers define action profile of Bial compound

New insight into BIA 10-2474 clinical trial shines light on preclinical testing

19-Jun-2017 By Melissa Fassbender

Experts are calling for an increased focus on human cellular model development after animal tests failed to detect the toxicity of an experimental drug before the first-in-human clinical trial that left one dead.

SGS bolsters E&L testing capabilities at Shanghai laboratory

15-Jun-2017 By Melissa Fassbender

SGS has increased its extractables and leachables (E&L) testing capabilities at its Shanghai, China-based laboratory.

Covance opens companion diagnostics laboratory

15-Jun-2017 By Melissa Fassbender

LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.

After doubling in size, LabConnect secures $24.5m investment

14-Jun-2017 By Melissa Fassbender

The global central laboratory and support services provider has secured a $24.5m Series A investment and is on track to double in size, again, over the next five years, says CEO.

'Easy to work with' tops CRO benchmarking report

05-Jun-2017 By Melissa Fassbender

With or without a preferred provider – what do pharma sponsors look for in a contract research organization?

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

31-May-2017 By Melissa Fassbender

This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others.

Pharma finance

Outsourcing-Pharma

Resources